Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

NCT03283059 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Octohydroaminoacridine Succinate
DRUG: Aricept
DRUG: Placebos

Sponsor

Shanghai Mental Health Center

Collaborators

[object Object]
[object Object]